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Molecular detection of viruses has been aided by high-throughput sequencing, permitting the genomic
characterization of emerging strains. In this study, we comprehensively screened 500 respiratory secretions
from children with upper and/or lower respiratory tract infections for viral pathogens. The viruses detected
are described, including a divergent human parainfluenza virus type 4 from GS FLX pyrosequencing of 92
specimens. Complete full-genome characterization of the virus followed, using Single Molecule, Real-Time
(SMRTH) sequencing. Subsequent ‘‘primer walking’’ combined with Sanger sequencing validated the RS
platform’s utility in viral sequencing from complex clinical samples. Comparative genomics reveals the
divergent strain clusters with the only completely sequenced HPIV4a subtype. However, it also exhibits
various structural features present in one of the HPIV4b reference strains, opening questions regarding
their lifecycle and evolutionary relationships among these viruses. Clinical data from patients infected with
the strain, as well as viral prevalence estimates using real-time PCR, is also described.
A
cute respiratory viral infections are among the most common infections in humans. Most provoke only
mild symptoms, but in some circumstances they may result in significant morbidity and mortality. In
particular, infections with novel viruses can be severe when the host lacks preexisting immunity, con-
ferred by prior encounters with the same or similar pathogens1. Not surprisingly, symptomatic respiratory tract
infections are notably frequent in infants and young children, making them the most common cause of hospit-
alization (in more developed countries) for patients below the age of five2.
The human parainfluenza viruses (HPIVs) are a group of four distinct serotypes of enveloped, non-segmented,
single stranded negative sense RNA viruses belonging to the Paramyxoviridae. They are a significant cause of acute
upper and lower respiratory tract infections in infants, frequently resulting in the need for in-patient care3. While
the epidemiology and clinical manifestations of HPIV1-3 is well characterized, much less is known about the 4th
serotype4. HPIV type 4 (HPIV4) was first identified in 1959 from a male college student exhibiting a mild upper
respiratory tract infection5, and has since been further divided into two distinct subtypes, 4a and 4b, based on
antigenic differences6. Compared to other HPIVs, HPIV4 has been infrequently isolated in cell culture due to
difficulties in propagation and a lack of cytopathic effects in most cell lines7,8. Moreover, the serotype has con-
ventionally been reported to display milder clinical symptoms, which has led to its exclusion from routine
diagnostic screening in most virology labs. By contrast, a number of studies have identified HPIV4 as a significant
cause of respiratory disease especially in children9–11. Infections in immunocompromised patients11 and in an
otherwise healthy adult12, resulting in acute respiratory failure, have been described. Recent epidemiological studies
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have shown that the clinical manifestations of HPIV4 resembled that
of other HPIVs13,14. Moreover, accumulating evidence from a number
of studies has identified HPIV4 as being more common than other
serotypes8,13,15,16. In summary, these studies suggest that both the pre-
valence and clinical importance of HPIV4 as a major cause of respir-
atory illness, especially in co-infections with other viruses, may have
been underestimated and remains poorly understood.
While specific and sensitive diagnosis of acute respiratory infec-
tions is important, in approximately 5-40% of cases (depending on
the season) no infectious agent is identified17. The application of new
sequencing methods to pathogen discovery can provide timely char-
acterizations of novel viruses from various pathological tissues18,19. In
this study, we comprehensively analyzed 500 respiratory samples
from children with upper or lower respiratory tract infections for
viral pathogens using a range of diagnostic techniques, including
immunological, and PCR-based assays as well as Roche Genome
Sequencer (GS) FLX Titanium pyrosequencing (Roche, Basel
Switzerland) of 92 specimens. The identification of a novel variant
(from a known viral pathogen) led us to further investigate its pre-
valence in these samples, and to characterize its genome by Single
Molecule Real-Time (SMRTH) sequencing of the original clinical
specimen on the PacBioH RS (PacBio) (Pacific Biosciences, Menlo
Park, CA). We additionally explore the feasibility of single molecule
sequencing, as well as verify the quality of the sequence obtained
through thismethod to the complete Sanger sequenced viral genome.
Results
Immunological and molecular screenings of respiratory samples.
Five hundred consecutive nasopharyngeal or tracheal aspirates from
children admitted to Odense University Hospital due to upper and/
or lower respiratory tract infection during the winter period of 2002 -
2003 were procured and analyzed for viral and bacterial pathogens.
Molecular and limited epidemiological data from these screenings is
reported in the supplementary results section, supplementary figure
S1 and supplementary tables S1, S2, S3, S4, and S5.
The Identification and prevalence of a novel human parainfluenza
virus type 4. An initial screening experiment of 92 pooled clinical
samples on the GS FLX Titanium platform resulted in a total of six
contigs and 39 singelton reads from one particular sample (459) with
a significant local BLASTn-mediated GenBank match of 87-96%
identity to HPIV4a. Presently, four complete genomes have been
sequenced across both HPIV4 subtypes (one HPIV4a and three
HPIV4b)20–22. Given that relatively little is known about these
viruses we set out to recover the full genome in this sample
(described below). We provisionally refer to this sequence as strain
HPIV4_DK(459).
The exclusion of routine HPIV4 screenings in the public health
setting in Denmark prompted us to also test the prevalence of this
virus in 493 respiratory specimens (7 samples of the original 500
could not be located) using reverse transcriptase (RT) real-time
PCR. PCR primers were designed from the HPIV4_DK(459)
sequences discovered during GS FLX Titanium sequencing. The pri-
mers amplify a 61-bp fragment of the hemagglutinin-neuraminidase
(HN) gene (see Material and Methods and table S6). PCR amplifica-
tion was observed in a total of 13 samples (2.6%). Through an epi-
demiological perspective, the prevalence of HPIV4 described in this
study corresponds to similar prevalence estimates to that of hMPV,
Adenovirus, and B. pertussis using PCR-based screenings (see
Supplementary Table S1).
Full genome of HPIV4_DK(459). Following the GS FLX screening
and analysis, we sequenced sample 459 on the PacBio RS to recover
HPIV4_DK(459) through a viral metagenomic framework. A total of
3,356,192 reads was generated from 5 SMRTcellsH of sequencing.
Viral read filtration of HPIV4 was achieved by mapping all
sequences using Pacific Biosciences BLASR software to five HPIV
reference genomes (x1 HPIV1, x1 HPIV2, x1 HPIV3, x1 HPIV4a,
x1 HPIV4b). This resulted in 116,109 reads (,3.5%) mapping to the
virus. Contigs were generated from filtered reads by de novo assembly,
resulting in an assembly of 29 contigs, which were subsequently
taxonomically identified through BLASTn (NCBI’s non-redundant
database). Despite sequence-independent amplification in the viral
metagenomic preparation resulting in predominately short frag-
ments as input (100–500 bp), up to 98% of the genome was
covered at 700X average coverage from the contigs alone. A compari-
son of the coverage obtained from viral metagenomic sequencing of
HPIV4_DK(459), (GS FLX and PacBio data) can be seen in Figure 1.
We later confirmed the full genome sequence of HPIV4_DK(459)
using conventional primer walking RT-PCR and 1st generation
Sanger sequencing from GS FLX data output (GenBank accession
number KF483663). The extremities (39 and 59 ends) of the geno-
me were acquired in similar fashion using a consensus alignment and
degenerate PCR amplification and Sanger sequencing. A list of the
primers used for primer walking is shown in Supplementary Table S7.
Using a simple majority-rule consensus approach, all positions with
more than 100X PacBio coverage were identical to the Sanger
sequenced genome, supporting the usefulness of this technique.
HPIV4_DK(459) genome analysis. The recovery and subsequent
alignment of the divergent Danish strain confirmed a similar
genomic orientation and content as found in the four other
sequenced HPIV4 genomes. The genome spans 17,098 nucleotides,
46-nt longer than the only reported complete HPIV4a genome and
more than 200-nt shorter than all three complete HPIV4b genomes
Figure 1 | Coverage plot of HPIV4_DK(459) (GenBank accession no. KF483663) from PacBio (blue line, left y-axis) and GS FLX reads (red line, right
y-axis) compared to the genome sequence derived from Sanger sequencing.
www.nature.com/scientificreports
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described to date. An initial comparison of nucleotide changes across
aligned HPIV4 genomes suggests that HPIV4_DK(459) appears
more closely related to the 4a subtype than any of the 4b subtype
strains (see Table 1). This is confirmed by phylogenetic analysis of an
alignment of the concatenated coding regions (Figure 2) as well as of
alignments of the entire genome (Supplementary Figure S2), and
each gene separately (Supplementary Figures S3-9) making it the
second HPIV4a genome sequenced to date.
The L gene in theParomyxaviridae encodes the catalytic subunit of
the RNA-dependent RNA polymerase protein used to transcribe and
replicate the HPIV genome3. As this gene is likely to be relatively
conserved, we chose it for inference of phylogenetic relationship to
other viruses within the Paramyxoviridae using amino-acid
sequences (see Figure 3). The analyses included members across
seven genera including, the Avulavirus, Henipavirus, Morbillivirus,
Respirovirus Rubulavirus, Pneumovirus and Metapneumovirus. As
expected, tree topology clustered HPIV_DK(459) with all other
HPIV4 genomes. Other members of the Rubulavirus genus,
HPIV2 and mumps, formed a sister clade to HPIV4. The overall
topology is congruent with previously published results23.
Comparative genomics. Although HPIV4_DK(459) clusters most
closely with HPIV4a than HPIV4b in all phylogenies, it shares four
distinct features with the HPIV4b isolate SKPIV420, which are absent
in all other completely sequencedHPIV4 genomes. Firstly, the isolate
does not obey the ‘rule of six’ (the number of nucleotides in the
genome being a multiple of six), a feature common for most but
not all paramyxoviruses24, which is thought to confer the ability of
the RNA polymerase to increase genome replication25.
Second, a 57-nt sequence-section is present at the 39 leader inter-
genic region upstream of the NP gene. This 57-nt sequence is ident-
ical with the corresponding SKPIV4 sequence in all but 3 nucleotides.
An initial prediction of this section’s RNA folding structure using
mfold26 demonstrates an impressive stem-loop configuration, which
folds into the exact same secondary structure (Supplementary Figure
S10) as the SKPIV4 isolate, despite the minor differences at the
nucleotide level. However, since single sequence secondary structure
alone is generally not statistically significant for determining the
presence of a structured RNA27, we undertook a more elaborate
analysis incorporating multi-sequence comparison and structural
RNA alignments. We extended the analysis to include 17 additional
Figure 2 | Maximum likelihood tree from all 7 concatenated open reading frames in human parainfluenza virus 4. The tree was generated using the
Tamura-Nei (TrN) nucleotide substitution model with 1000 bootstrap replicates, and midpoint rooted for clarity. Scale bar represents estimated
phylogenetic distance in substitutions per site. HPIV4 strains are labeled with strain name and GenBank accession number on the right. The reported
Danish strain, HPIV4_DK(459) (GenBank accession no. KF483663), is shown in red boldface.
www.nature.com/scientificreports
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Paramyxoviridae 3’ proximal sequences from the genera Rubulavirus
(HPIV2, HPIV4, Mumps, Simian virus 41, PIV5, Achimota 1, To-
huko 2, Menangle, Tioman), Henipavirus (Nipah virus), Mor-
billivirus (Measles), Respirovirus (HPIV1, HPIV3), and Avulavirus
(Newcastle disease). A primary sequence alignment (Supplementary
Figure S11) shows that taxa can be divided into two groups - those
with , 100 nts 3’ proximal sequences and those with , 150 nts 3’
proximal sequences. The insert appears to be present in some
Rubulaviruses whereas it is absent in the other genera. In order to
estimate the reliability of the potential RNA structure we performed a
comparative RNA structure analysis with a number of Rubulaviruses
with 3’ intergenic regions of similar lengths to the HPIV4_DK(459)
Figure 3 | Maximum likelihood phylogenetic tree of the L protein withinmembers of the Paramyxoviridae. The tree was generated using the LG1G1
F amino acid distance matrix with 200 bootstraps replicates and midpoint rooted for clarity. Branch length is proportional to estimated phylogenetic
distance in amino acid substitutions per site. All viruses are labeled with respective L protein identifier from UniProt, followed by virus abbreviation as
follows: human metapneumovirus (hMPV), respiratory synctial virus (RSV), Newcastle disease virus (NDV), human parainfluenza 1-4 (HPIV1-4),
Mumps virus (MuV), Sendai virus (SeV), Rinderpest virus (RPV), Measles virus (MeV), Nipah virus (NV), Hendra virus (HeV). HPIV4 strains are
additionally labeled with strain name. The reported Danish strain, HPIV4_DK(459) (GenBank accession no. KF483663) is shown in red.
Figure 4 | Structural alignment of 150nt 39 proximal sequences from Rubulaviruses produced with Stral and PETfold. A 100 nt HPIV4 sequence is
overlaid showing the position of the insert with respect to the structure. Brackets refer to intra-molecular base-pairs of the RNA secondary structure.
The extent of compensatory base changes is indicated using the Vienna RNA conservation coloring scheme31. The color indicates what type of base pair is
formed (e.g. CG, AT, GU) and the strength of the color indicates the degree of conservation of the compensatory base change. The central stem
structure is supported by the consensus structure of CMfinder, locarna, mxcarna, MASTR and PETfold29. The AUG at the end of each sequence is the
start-codon of the NP gene. All viruses are labeled with virus name followed by GenBank accession number.
www.nature.com/scientificreports
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sequence. Figure 4 shows the structural alignment produced using
StrAl28 and PETfold29 via the WAR web server30. The central part of
the conserved hairpin structure is also supported by MASTR,
locarna, mxcarna, CMfinder and PETfold (http://genome.ku.dk/
resources/war/). Using the sequenced genome of HPIV4_DK(459)
we later designed a simple diagnostic real-time PCR assay (see
Material and Methods and Supplementary Table S6) to test whether
any other (n 5 12) HPIV4 positive samples possessed the 57-nt
sequence-section. Duplicate PCR amplification and subsequent
Sanger sequencing confirmed that a minimum of 3 other samples
(118, 294 & 309) contained the ‘insert’, suggesting that it is common
among circulating Danish HPIV4 strains.
Thirdly, both genomes share an identical stretch of 13 amino-acid
residues within the HN gene (TQLLTYISYNGTI), only one of which
is conserved in all published complete HPIV4 genomes. Importantly,
visual examination of aligned HN ORF nucleotide sequences (from
all currently available HPIV4 sequences in GenBank [n5 29]) iden-
tified this stretch of amino acids in all but nine strains across both
HPIV4 subtypes, which suggests a high prevalence among the
HPIV4 strains. The differences observed in this section are due to
three insertions-deletions (indels) across the strains that result in a
frame shift at the amino acid level in this section. Based on this
observation, up to five distinct genotypes can be visually identified
from this data, three of which differ at only a single amino acid. This
information is visually represented in Figure 5. An amino acid align-
ment of the HN gene from completely sequenced HPIV4 strains to
two other paramyxoviruses (HPIV3, NDV) whose three-dimen-
sional protein structure has been described using X-ray crystal-
lography32,33, places this stretch of 13 residues in the second Beta
sheet, third strand (b2S3) of the globular head of the molecule.
Meaningful inference of this sort is supported by the fact that the
position of the protein structures of NDV and HPIV3 are highly
conserved even though they are phylogenetically more distant, than
either is toHPIV4. This structure is shown forHPIV3 andNDV to be
immediately preceded by the a1 helix, which is seemingly crucial for
the enzymatic activity of the protein32. Lastly, both HPIV4_DK(459)
and SKPIV4 have a longer ORF at the C-terminal end of the HN
gene, which codes for an extra five amino acids, the two first of which
are identical. However, as above, (from a comparison of available HN
sequences) the presence of the longer HN ORF appears more pre-
valent than its absence across strains. Using the same paramyxovirus
alignment above, the C-terminal end of the HN gene can be inferred
to reside in the end of the 6th Beta sheet, third strand (b6S3) of the
globular head of the protein molecule. This beta sheet has been
identified as having catalytic/active sites in both the first and second
strand32. The amino acid residue differences within the HN gene of
Figure 5 | Maximum likelihood tree fromaligned hemagglutinin-neuraminidase gene in human parainfluenza virus 4. The presence of three indels in a
section of approximately 60 nucleotides results in a frame-shift and changes at the amino acid level, generating five genotypes (one which is shared across
both subtypes), highlighted in red (TQLLTYISYNGTI), orange (TQLFTYISYNGTI), purple (TQLLTYVSYNGTI) blue (LNWQHNYLHTYHIMVPL)
and green (NNYLHIMVLSKI). The tree was generated using the HKY85 nucleotide substitution model with 1000 bootstrap replicates, and midpoint
rooted for clarity. Scale bar represents estimated phylogenetic distance in substitutions per site. HPIV4 strains are labeled with strain name and
GenBank accession number on the right of the sequence name. The reported Danish strain, HPIV4_DK(459) (GenBank accession no. KF483663), is
found in red under the HPIV4a subtype.
www.nature.com/scientificreports
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each of the five sequenced HPIV4 reference genomes can be visua-
lized in Supplementary Figure S12.
Discussion
Advances in molecular technologies have allowed ever more rapid
and sensitive identification of etiological agents of infectious diseases,
including epidemics. In clinical virology, PCR based assays still
remain the gold standard. However, their high specificity and the
emergence of divergent strains may cause the assay to fail routine
diagnosis, leading to elevated levels of false negatives. High-through-
put metagenomic sequencing provides an alternative measure, by
supplying added sequence information and revealing details on the
divergence to characterized strains. Here we show that not only 2nd
generation sequencing platforms, but also 3rd generation singlemole-
cule sequencing may be used effectively in viral discovery. Although
one of the primary strengths of the PacBio lies in the generation of
long sequences, the platform can clearly be used for short read
sequencing. The pre-sequencing amplification methods used in this
study primarily generated short input fragments. However, using few
SMRT cells we obtained excellent coverage of the genome. Given its
fast turnaround time, the PacBio is well suited for rapid and relatively
cheap characterization of novel viruses. In particular, when other
more sensitive screening (sequencing) platforms have identified can-
didate viral reads within the clinical samples tested.
Amongst the identified viruses using deep sequencing was the
presence of a divergent HPIV4. HPIV4 has been traditionally
described as fastidious in nature, and less clinically important than
other HPIV serotypes4. Overall this has resulted in few epidemiolo-
gical and case report studies being published34, and its infrequent
screening in clinical microbiology laboratories11. In temperate cli-
mates, peak incidence of HPIV4 is often reported during the late fall
and late winter months4,14,16,34. However, other studies have detected
peaks outside the usual seasons13,34, emphasizing a poorly understood
epidemiology and seasonality35. Aside from this consideration, sev-
eral other factors may influence its detection including geographical
location, sample population, and the year of collection8,11. Although
the identified proportion of HPIV4 positive samples in our study was
within previously described ranges, the aforementioned factors will
likely result in significant differences across spatial and temporal
distributions. More importantly, the lack of complete genomes con-
firms how little is known of circulating HPIV4 viral strains, emphas-
izing the need for focused full genome studies. In accordance with the
above, we recovered the full genome of a divergent HPIV4 in a proof
of principle study using 3rd generation metagenomic sequencing.
Despite the short lengths of the amplicons, confirmatory Sanger
sequencing later attested to the validity of this approach in virus
discovery.
All phylogenetic analyses convincingly grouped HPIV4_DK(459)
with HPIV4a (see Figure 2 and Supplementary Figures S2-9)
However, interestingly, strain HPIV4_DK(459) shares various fea-
tures with one HPIV4b isolate (SKPIV4), which phylogentically
otherwise appears the more distantly related to HPIV4_DK(459)
in all but two analyses performed. This included the presence of a
57-nt sequence section at the 39 leader intergenic region prior to the
NP gene. Given that conserved promoter sequences in this region of
PIV’s is believed to drive transcription and replication of nascent
RNA into postive-sense RNA replicas24, it makes it alluring to specu-
late on the functional role of this section. Interestingly, a number of
the Paramyxoviridae have 3’ intergenic regions (up to the start codon
of the NP gene) of around 150 nts, approximately the same length as
the HPIV4_DK(459) strain and SKPIV4 sequences. In silico gener-
ated RNA structure analysis revealed that the only consistent con-
sensus secondary structure overlaps the 57-nt ’insert’ region (see
Figure 4). These results indicate that the insert is potentially neces-
sary for RNA secondary structure formation that seems to be con-
served across different members of the Paramyxoviridae. The 3’
leader sequence is known to be involved in RNA replication, tran-
scriptional and encapsidation regulation36. The potential regulatory
consequences of the putative RNA structure in the leader sequence
remain to be examined.
Moreover, under the premise that the ends of the genome were
suitably acquired, neither genome conforms to the rule of six, a
feature thought to influence replication efficiency within the Para-
myxoviridae37. Two additional features shared with the SKPIV4
strain are both located within the HN gene, which encodes one of
two proteins expressed on the viral surface. The HN envelope gly-
coprotein has three important functions. First, it mediates cellular
infection through binding of the virus to cell-surface receptors con-
taining sialic acid. Second, it severs the binding of the cells receptor
from the glyco-protein conjugates during viral budding. Finally,
through interaction with a second surface glycoprotein, it regulates
fusion between the virus envelope with the cells plasmamembrane24.
Here, we have provisionally inferred the location of these conserved
residues by aligning the HN gene to two members of the Para-
myxoviridae (NDV, HPIV3), whose crystallographic three dimen-
sional protein structures have been described32,33. However, the
biological and functional relevance, such as the mediation of cellular
receptor binding or Fusion protein activation remains unclear.
Previous studies have ascertained that both the stalk region and
the globular head are functionally important38, thus investigation
of these mechanisms will require various directed studies.
While it will become important to clarify the functional role of the
shared features between HPIV4_DK(459) and SKPIV4 (if any), it is
equally intriguing to speculate on their evolutionary history.
Although the differences described in our viral strain (within the
HN gene) can be attributed to a number of indels, the presence of
the 57-nt sequence-section cannot. The occurrence of this common
sequence-section acrossHPIV4 subtypesmay be explained through a
common evolutionary history.
The high level of selective pressure on the HN gene by the host’s
immune system suggests that these features (the stretch of 13 amino
acid sequence section and the ends of the HN genes) might be under
strong positive selection, which is clearly supported by their positions
in the putative protein structure. Additionally, this might also be the
case for the RNA hairpin structure, which potentially regulates part
of the viral life cycle. Indeed, studies of individual viral genera do
indicate varying patterns of selection acting within different genes.
However, testing such effects at different taxonomic hierarchical
levels are likely to be problematic given low species sampling sizes23.
The lack of genomic data and the neglected epidemiology of
HPIV4 leave questions unanswered. Although our results link
HPIV4_DK(459) to the SKPIV4 isolate, the implications of these
conserved regions in the genome is presently unclear. Further reso-
lution into the location of these conserved residues, perhaps begin-
ning with crystallographic structural analysis of HN proteins or
protein folding prediction, may shed light on their function.
Moreover, having described the precise location on the molecules
three-dimensional structure, site-directed mutational studies could
further resolve their biological relevance39. With reduced costs in
high-throughput sequencing future studies should additionally aim
on recovering complete high quality genomes from various HPIV4
strains. Such an endeavor, will further resolve evolutionary relation-
ships between homologous serotypes, HPIV4 subtypes, and sister
species.
Methods
Respiratory specimens. Five hundred nasopharygeal aspirates or tracheal secretions
previously collected from children during the winter season of 2002-2003 admitted to
Odense University Hospital, Denmark were procured. All samples were taken from
children of ages 0 to 5 years hospitalized for symptoms of acute respiratory infection.
Laboratory and limited clinical data was collected and samples subsequently
anonymized.
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Immunological and RT-PCR based pathogen screening. All samples were initially
tested for respiratory syncytial virus using either Immunofluorescence (Dako) or
rapid immunological tests performed with membrane ELISA (Beckton-Dickenson).
As only 36% of the samples collected during the RSV season tested positive, we tested
for a range of pathogens (RSV, influenza A and B, human metapneumovirus,
parainfluenza type 3, coronavirus OC43, NL-63 and 229E, rhinovirus, enterovirus,
parechovirus, adenovirus, bocavirus, Mycoplasma pneumonia, B. pertussis and C.
pneumoniae) using RT-PCR and PCR with amplicon hybridization to probe coated
microtiter plates as described elsewhere40–42. From this cohort of 500 respiratory
samples, 92 samples that tested negative after the aforementioned diagnostic tests
were subjected to viral metagenomics to fill the diagnostic gap.
Viral particle purification and extraction for GS FLX sequencing. A volume of
500 ml from 92 respiratory aspirates were clarified by centrifugation at 12,000 rpm for
2 mins to pellet any cellular debris. The supernatant was then collected and passed
through a 0.45 mM sterile filter (Millipore) at 12,000 rpm for 5 minutes for further
removal of cellular material and bacterial sized particles. The filtrates were collected
and spun in an ultracentrifuge (Beckman Coulter Optima LE-80) at 32,000 rpm for
two hours at 8uC. Sample supernatant was discarded, and viral particles resuspended
with 110 ml of Hanks buffered saline. Subsequently, the filtrates were treated with a
cocktail of DNase and RNase enzymes that included Turbo DNase (Ambion),
Baseline ZERO (Epicentre), Benzonase (Novagen), RNase A (Fermentas) in a x1
Turbo DNase reaction buffer to remove unprotected nucleic acids as previously
described18. Viral nucleic acids were then extracted using the QIAamp viral RNA
extraction kit (Qiagen) according to the manufacturers instructions.
Respiratory virome library construction for GS FLX sequencing. Nucleic acid
extracts from each sample were treated separately in either ‘RNA only’ or an ‘RNA
and DNA’ sequence-independent amplification route as described previously18,43.
Briefly, 10 ml of extracted nucleic acids was incubated with DNase (Ambion) for an
RNA virus-only enrichment. For the RNA and DNA enrichment the nuclease
treatment step was omitted. Both reactions were then reverse transcribed using
Superscript III (Invitrogen) and 100 mM of a distinct random primer consisting of a
20-bp nucleotide sequence at the 5’ end and a randomized octamer sequence at the 3’
end. Following reverse transcription, the cDNAwas made double stranded by using a
single round of Klenow fragment polymerase (New England Biolabs). PCR
amplification was performed in duplicate for both the RNA and RNA plus DNA
fractions by using primers consisting of only the 20-bp fixed portion of the random
primer. This resulted in a total of four PCR reactions per sample, which was
subsequently pooled and purified using the QIAquick PCR purification kit (Qiagen)
and the DNA concentration determined by nanodrop (Thermo scientific). The
amplified products were run on a 2% agarose gel, yielding aDNA smear. Fragments of
approximately 500 to 1000-bp were excised from the gel, and purified using the
QIAquick Gel Extraction Kit (Qiagen). Equimolar concentrations of amplified
samples were pooled and built into two separateDNA libraries and run on theGS FLX
titanium platform (454 Life Sciences).
GS FLX pyrosequencing read analysis. Sequence reads were filtered through
sequence similarity to local human (human genome hg18) and ribosomal sequence
databases using BLAT. Remaining filtered reads were then identified and binned
according to the different PCR primers used to amplify the sample. Each read was
subsequently trimmed of the primer consisting of a fixed 20-bp nucleotide sequence
and an adjacent 8-bps representative of the random portion of the primer. All filtered
reads were later mapped against the European Bioinformatics Institute’s (EBI) viral
and phage genome reference databases (http://www.ebi.ac.uk/) using ssaha2 for
taxonomic identification44. Additionally, filtered binned reads were built into contigs
using Newbler, and taxonomically identified by comparison to GenBank (best hit) as
bacterial, viral or unknown using BLASTn and BLASTx searches. A cutoff off value of
# 1025 was used for determination of the significance of a hit. Any sequence with an E
value of . 1025 was deemed unclassifiable and removed.
Viral particle purification and extraction for PacBio RS sequencing. Complete
genome sequencing of the divergent HPIV4 (sampe 459) was performed through a
metagenomic framework and sequenced on the PacBIO RS. The viral particles were
treated in a manner like the 454 sequencing experiment, but with a few notable
exceptions. Three aliquots of 150 ml of respiratory sample was clarified and filtered in
a 0.45 mM sterile filter (Costar) as described above. Nuclease treatment employed
double the concentration previously described18. All other experimental processes up
to and including the PCR product pooling and purification was performed alike the
454-processing-pipeline with the exception that 8 amplifications (x4 RNA only and
x4 RNA plus DNA) were performed. Subsequently, the purified DNA products were
measured using a Qubit fluorometer (Invitrogen), built into libraries and sequenced.
PacBio RS library construction and sequencing. Small fragments (,100 bp) in the
DNA sample were removed prior to library construction with one purification of 1.8
3 volumes of Agencourt AMPure XP beads (Beckman Coulter Genomics) as per the
manufacturers instructions. Fragment size assessment and quantification was verified
using a Bioanalyzer 2100 with DNA 7500 chemistry (Agilent). A single SMRTbell
library was generated using standard reagents and protocols (overhang ligation
protocol). As the input fragments are significantly smaller than those previously
tested on the PacBio RS, we sequenced the library at 5 different on-chip
concentrations (80 pM, 40 pM, 20 pM, 10 pM, 5 pM).
PacBio RS sequence analysis. Total sequence output from the five SMRTcells was
then filtered by mapping against five HPIV reference genomes (HPIV1 -
NC_003461.1, HPIV2 - NC_003443.1, HPIV3 - NC_001796.2, HPIV4a -
AB543336.1, HPIV4b - EU627591.1) using BLASR. To increase the stringency of the
bioinformatic approach, mapped HPIV4 reads were further filtered on a minimum
pass accuracy of 80% andminimum read length of 100-bp. Assembly of filtered reads
into contigs was subsequently achieved using the Allora software45 then
taxonomically identified using BLASTn by comparison to GenBanks non-redundant
database.
Sanger sequencing. Primer walking and Sanger sequencing was additionally used to
obtain the full genome of HPIV4_DK(459) and for confirmation of the amplified 57
nucleotide insert. All homologs (singlet reads and contigs from GS FLX data)
matching HPIV4_DK(459) were aligned with the four currently available HPIV4
genomes in GenBank (HPIV4a - accession numbers AB543336.1, HPIV4b -
accession numbers EU627591.1, AB543337.1, JQ241176.1) using Geneious v5.4.2
software46. Multiple primer sets were designed from the alignment, including
consensus primers to fill the ends of the sequences and any significantly large gaps
within the genome. Primers were designed using Primer347 and prepared by Eurofins
MWGOperon, Ebersberg Germany (Supplementary Table S2). Amplification of each
viral target was achieved by using a OneStep RT-PCR kit (Qiagen) in a 50 ml reaction
volume. The final reaction mixture contained 1x OneStep RT-PCR buffer, 400 mMof
each deoxynucleoside triphosphate (dNTP), 2.5 mM of MgCl2, 0.6 mM of each
primer, and 2 ml of OneStep RT PCR enzyme mix. PCR cycling conditions varied
depending on the estimated size of the amplified product (Supplementary Table S2).
Amplified material was sent to Macrogen (The Netherlands) for purification and
Sanger sequencing in both directions by following the companies recommendations
and use of the same PCR amplification primers for sequencing. Following full genome
recovery, sequenced fragments were aligned to the four reference genomes and then
assembled using Geneious v5.4.246.
To compare genome coverage between GS FLX and PacBio RS, unfiltered GS FLX
and PacBio reads were mapped against the Sanger sequences obtained by Primer
Walking using ssaha244. Using the pileup feature in samtools48, the number of reads
with base calls divergent from the consensus were recorded and plotted along with
coverage.
Real-time quantitative PCR (qPCR) of divergent HPIV4. Nucleic acid extraction.
Viral RNAwas extracted from respiratory secretions using theMagNa Pure LC Total
Nucleic Acid Isolation Kit (Roche Diagnostics) on the KingFisher semi-automated
magnetic particle processor (Thermo Scientific) following the manufacturers
instructions. For quality control purposes, two negative template controls (one per
plate) were simultaneously extracted in each KingFisher run, where sample was
replaced with sterile water (Ambion). Nucleic acid extractions from each respiratory
secretion or negative template control were then stored at -20uC in RNase free
microfuge tubes.
Multiplexed real-time PCR primers, probes and positive controls.Aligned pyrosequen-
cing data (described above) was used to design amultiplexed TaqMan qPCR assay for
qualitative detection of a 61 bp fragmentmatching the HN gene in HPIV4_DK(459).
All real-time primers and probes (Supplementary Table S6) were designed using
Primer3 software48 and prepared by Pentabase (Odense Denmark). To ensure ana-
lytical performance, a synthetic DNA control was designed consisting of the same
primer and probe sites for the HPIV4 target (HN real-time assay not insert real-time
PCR assay) and an additional 5 S ribosomal RNA sequence for distinction between
real and false positives. The DNA oligonucleotide was ordered from Pentabase
(Odense Denmark), (59CAAACCCATTGGTGTTATACCCAGTAGTTTGATT-
GCTAGATGCAGGGTCTGCACAGTTGTGCAGTGTCTGCACATCCTTGTAG-
GAGTCGTGCGTCGATGAAGAACGCAAGTGCAATCAATATGTATCACTAG-
GAACC39).
Real-time PCR ‘insert’ assay. A real-time RT-PCR assay was also designed on the
aligned genomes (using Geneious)46 of all five completely sequenced HPIV4 strains.
The primers were designed using the same software (as above) and prepared by TAG
Copenhagen (Copenhagen Denmark).
Real-time PCR assays. All real-time RT-PCR assays used 5 ml of template nucleic
acids from each respiratory sample to 20 ml of reaction mix. The reaction mix was
made using the OneStep RT-PCR kit (Qiagen) and contained 5X OneStep reverse
transcription (RT)-PCR buffer, 400 mM of each deoxynucleoside triphosphate
(dNTP), 2.5 mM of MgCl2, 0.5 mM of each primer, 0.1 mM of the TaqMan probe
and 1 ml of OneStep RT PCR enzyme mix. PCR cycling consisted of an initial cDNA
synthesis step at 50uC for 30 min followed by an initial denaturation step at 95uC for
15 min and then 45 cycles of amplification at 95uC for 15 s, 55uC for 60 s and 72uC
for 15 s. Real-time amplification was performed on the Roche LC480 light cycler.
Negative template controls and multiple diluted positive controls were simulta-
neously run in all (HN assay only) real-time PCR reactions.
Phylogenetic analysis. Human parainfluenza viruses type 4 (HPIV4). Alignment of
the full Sanger sequenced genome of isolate HPIV4_DK(459) and all the four other
available HPIV4 reference genomes, as well as all coding regions, individually and
concatenated, were achieved using the MAFFT plug-in49 in Geneious46 with
subsequent visual inspection and manual correction. Signs of saturation on the third
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codon postion of the alignments were tested using DAMBE50, but none were found.
Nucleotide substitutionmodels were chosen using the Bayesian Information criterion
inModelGenerator51 andMaximum likelihood trees built using the PHYML plugin52
in Geneious with 1000 bootstrap replicates. All trees were visually inspected and
annotated using the FigTree graphical viewer interface version 1.3.1
(http://tree.bio.ed.ac.uk/software/figtree/) including mid-point rooting for clarity.
Paramyxoviruses. A phylogenetic relationship within the Paramyxoviridae was
inferred using amino acid sequences from the L protein. Sequences were imported
from the UniProt database, - including multiple paramyxoviridae strains (n5 31) in
addition to the x5HPIV4 sequences (see protein identifiers on tree) - and, three initial
alignments constructed using three different scoring matrices (Blosum62, Jtt100,
Jtt200) to compare the quality of the alignments. All matrix alignments were per-
formed in Geneious v5.6.446 using the MAFFT v6.717 b plugin49 and the standard
open gap penalties, and offset values. The Blosum62matrix produced the best quality
alignment based on direct visual inspection and using Entropy-Two (www.hiv.-
lanl.gov). This alignment was then refined using the Geneious Alignment software46.
Amino-acid saturation was tested using ASaturA53, and together with visual inspec-
tion this led to the removal of a significant number of sites including virtually all gap
containing positions and their often ambiguously aligned neighboring positions,
resulting in a final alignment, 1567 amino acid residues in length. ProtTest54 was used
to test the models of protein substitution; both the AIC, AICc and BIC criteria chose
the LG (Le Gascuel)1 G1 F as the best fit55 The online version of PhyML52, (http://
www.atgc-montpellier.fr/phyml/) was used to infer the Maximum Likelihood tree
using 200 bootstrap replicates. The tree was then visualized and annotated using the
FigTree graphical viewer interface version 1.3.1 (http://tree.bio.ed.ac.uk/software/
figtree/) including mid-point rooting for clarity.
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